Kamdar, M., Solomon, S. R., Arnason, J., Johnston, P. B., Glass, B., Bachanova, V., Ibrahimi, S., Mielke, S., Mutsaers, P., Hernandez-Ilizaliturri, F., Izutsu, K., Morschhauser, F., Lunning, M., Chow, V. A., Montheard, S., Santamaria, J., Colicino, S., Ogasawara, K., Stepan, L., Liu, F. F., Abramson, J. S. (2025). Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00399